Technology that enhances specificity and sensitivity.

Unlike conventional techniques that assume and execute blindly and lack sensitivity and specificity multiplex offers a wide range of testing panels that identifies the target pathogen in any clinical settings. For an example, with similar signs syndromes or disease.

Technology that is gold standard for real time quantification.

Today, everything laboratory all over the country in. recently utilizes etheric genome sequencing or FlimArray technique for diagnosis of infectious diseases. Although these techniques are familiar, they lack the advantages offered by RT-PCR technique, used in multiplex, being the gold standard in the industry, Reverse Transcription Polymerase Chain Reaction. (RT-PCR) provides several benefits.

Real time quantification with high degree of analytical precision.

Ability to provide quantitative interpretation.

Simultaneous analysis of hundreds of samples.

High sensitivity and specificity.

Technology that holds the promise of first choice.

Instead of being the last resort, multiplex must be considered as the first choice that offers high chances of pathogen detection during initial phases.

Technology that enables less time and cost.

Multiplex adheres to an outstanding multiplex pathogen targeting diagnosis, being an economical and well within the reach of the customers. Simultaneous screening of multiple pathogen shapes time, while usage of a few reagents, rather than multiple reagents for each pathogen, reduces the cost markedly.

With CE approval, multiplex technologies strives to target multiple India-specific pathogens, which more than 200 assays our multiple target capability, combined with in-house technical expertise, makes us the pioneer in infectious disease testing.